Markers and kits for detecting Escherichia coli in marmots
By discovering and verifying the characteristic peptides of Escherichia marmot in MALDI-TOF MS technology, a kit was developed to solve the problem of difficulty in identifying Escherichia marmot, and a fast, accurate and low-cost screening was achieved. in clinical and public health testing.
Patent Information
- Application Number
- CN202411132606.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-19
AI Technical Summary
The existing detection methods are difficult to accurately distinguish Escherichia marmot from Escherichia coli and Shigella, which makes it difficult to identify. The whole genome sequencing technology is costly and lasts long, so it cannot be used for clinical or disease control testing.
By conducting statistical analysis of bacterial genus and species data at the level of peptides, combined with MALDI-TOF MS technology, the characteristic peptides of Escherichia marmot were discovered and verified, and a fast and high-throughput kit was developed to distinguish marmot Escherichia and other pathogens.
It has achieved accurate and specific screening of Escherichia marmot, reduced testing costs, and is suitable for batch rapid testing, and is suitable for clinical infection diagnosis, monitoring and public health emergency response.
Smart Images

Figure CN118641777B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of microbial detection, in particular to a marker and a kit for detecting Escherichia coli. Background Art
[0002] Escherichia coli Escherichia marmotae ) is a new Escherichia pathogen isolated from the intestine of Himalayan marmot in 2015 and named as a new species. In vitro infection experiments and virulence gene analysis predictions have shown that Escherichia coli is a potential human infection pathogen. In the past two years, more and more reports internationally have shown that Escherichia coli can cause invasive human infections involving blood, bones, urinary tract, bile duct system, septic shock, etc., and is highly positively correlated with Alzheimer's disease. Escherichia coli also has the ability to acquire broad-spectrum β-lactamases and has the potential to become a super-resistant bacterium. Escherichia coli is a closely related bacterium to Escherichia coli and Shigella, and is very similar in genome and peptide spectrum. Therefore, the conventional matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) technology used for culture colony detection cannot distinguish Escherichia coli from Escherichia coli and Shigella. At present, there are more than 80 strains of Escherichia coli isolated from marmots in the world, all of which were confirmed from the screened "Escherichia coli" through whole genome sequencing technology. Discovering new pathogens and evaluating their pathogenicity, transmission ability, and their epidemic risk and public health significance in the population are of great significance for preventing major emerging infectious disease events in the future. Therefore, the development of detection and infection diagnosis methods for emerging pathogens is crucial to achieve active monitoring and prevention of major infectious disease outbreaks based on reverse microbial etiology.
[0003] At present, due to the limitations and singleness of the detection methods, it is still difficult to detect and isolate Escherichia coli. Moreover, using molecular biological methods such as PCR and MALDI-TOF MS mass spectrometry microbial identification technology, Escherichia coli is identified as Escherichia coli. Whole genome sequencing is currently the only method for the identification of Escherichia coli. Due to its high technical requirements, high detection and analysis costs, and long time, this method is only suitable for the detection and analysis of key pathogens, and is not suitable for clinical or disease control detection and monitoring sample screening.
[0004] In order to enhance the isolation and monitoring capabilities of Escherichia coli in marmots and make full use of mature and recognized detection equipment resources, the present invention has developed a method and kit for rapid, high-throughput and accurate screening of Escherichia coli in marmots based on MALDI-TOF MS, providing technical support for the prevention and control of infectious diseases related to Escherichia coli in marmots. Summary of the invention
[0005] The invention provides a marker and a kit for detecting Escherichia coli in marmots.
[0006] The object of the present invention is to provide a marker, a kit and a method for rapid screening of Escherichia coli based on MALDI-TOF MS technology, which are used to accurately distinguish Escherichia coli from other pathogens. To achieve the above object, the present invention first statistically analyzes a large amount of bacterial genus and species data at the peptide level, combines culture omics with mass spectrometry technology, and finds statistically significant difference peaks (peptides) in the range of 2000-20000Da between Escherichia coli and non-Escherichia coli pathogens, and uses software to compare and analyze a total of 272 peptide mass fingerprints of Escherichia coli and Gram-negative and Gram-positive bacteria including all serotypes of Escherichia coli, Shigella and other species. Combining the comparison analysis results of the two software and the two methods, four characteristic peptides of Escherichia coli were determined, and 258 strains of bacteria including 60 genera and 193 species were used to verify the accuracy and specificity of the characteristic peptides. The results showed that the identification accuracy and specificity were both 100%. Furthermore, the present invention provides a MALDI-TOF MS rapid detection kit based on the above-mentioned characteristic peptide segment, which is used for rapid screening of Escherichia coli from isolated and cultured pathogens or samples, effectively solving the problem of confirming and identifying the emerging pathogen Escherichia coli by relying solely on whole genome sequencing.
[0007] Specifically, the present invention provides the technical solution described below.
[0008] In a first aspect, the present invention provides an application of a characteristic peptide combination as a marker for detecting Escherichia coli or in detecting Escherichia coli, wherein the characteristic peptide combination includes four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively.
[0009] The above-mentioned characteristic peptide combination can be used as a marker for the detection of marmot Escherichia coli, to distinguish marmot Escherichia coli from non-marmot Escherichia coli, or to detect whether marmot Escherichia coli exists in a sample, or to detect marmot Escherichia coli infection, with high specificity and accuracy.
[0010] Specifically, the application includes: performing MALDI-TOF MS detection on the protein of the microorganism to be detected. If the MS spectrum of the protein of the microorganism to be detected simultaneously has characteristic peaks of four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively, then the microorganism to be detected contains Escherichia coli, otherwise the microorganism to be detected does not contain Escherichia coli.
[0011] In the present invention, the protein of the microorganism to be detected is a small protein or polypeptide with a molecular weight of 2000-20000Da.
[0012] In a second aspect, the present invention provides the use of a reagent for detecting a characteristic peptide combination in the preparation of a kit for detecting Escherichia coli or screening for Escherichia coli infection in marmots, wherein the characteristic peptide combination includes four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively.
[0013] Preferably, the reagent is a reagent for detecting characteristic peptide segments based on MALDI-TOF MS technology.
[0014] In a third aspect, the present invention provides a marker for detecting Escherichia coli, the marker comprising four characteristic peptide segments with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively.
[0015] The MALDI-TOF MS characteristic peaks corresponding to the four characteristic peptide segments of the present invention have the following characteristics: characteristic peak 1: mass-to-charge ratio m / z: 2882.70±1.06, signal-to-noise ratio s / n: 22~83, resolution: 367~498, peak intensity: 2135-18558, peak area: 21165-195762; characteristic peak 2: mass-to-charge ratio m / z: 4853.93±2.22, signal-to-noise ratio s / n: 2~10, resolution: 310~665, peak intensity: 276-2565, peak area: 1098-31 636; Characteristic peak 3: mass-to-charge ratio m / z: 5764.78±2.31, signal-to-noise ratio s / n: 69~247, resolution: 319~552, peak intensity: 10477-33264, peak area: 206618-793495; Characteristic peak 4: mass-to-charge ratio m / z: 10516.16±4.23, signal-to-noise ratio s / n: 4~19, resolution: 511~992, peak intensity: 317-1726, peak area: 2853-35849.
[0016] In a fourth aspect, the present invention provides a kit for detecting Escherichia coli in marmots, the kit comprising a positive standard and one or more selected from a standard calibration solution, a bacterial protein extract solution, and a matrix saturated solution;
[0017] The kit detects proteins of the microorganism to be detected based on MALDI-TOF MS. If the MS spectrum of the protein of the microorganism to be detected simultaneously has characteristic peaks of four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively, the microorganism to be detected contains Escherichia coli, otherwise the microorganism to be detected does not contain Escherichia coli.
[0018] Preferably, the protein of the microorganism to be detected is a small protein or polypeptide with a molecular weight of 2000-20000 Da.
[0019] The MS spectrum of the positive standard described above simultaneously has characteristic peaks of four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively.
[0020] Preferably, the positive standard is a protein of Escherichia coli.
[0021] Preferably, the characteristic peak of the characteristic peptide segment with a mass-to-charge ratio of m / z of 2882.70±1.06 also has the following characteristics: signal-to-noise ratio s / n: 22~83, resolution: 367~498, peak intensity: 2135-18558, peak area: 21165-195762; the characteristic peak of the characteristic peptide segment with a mass-to-charge ratio of m / z of 4853.93±2.22 also has the following characteristics: signal-to-noise ratio s / n: 2~10, resolution: 310~665, peak intensity: 276-2565, peak area: 1098-31636; the characteristic peak of the characteristic peptide segment with a mass-to-charge ratio of m / z of 5764.78±2.31 The characteristic peaks of the characteristic peptide segment also have the following characteristics: signal-to-noise ratio s / n: 69~247, resolution: 319~552, peak intensity: 10477-33264, peak area: 206618-793495; the characteristic peak with a mass-to-charge ratio m / z of 10516.16±4.23 also has the following characteristics: signal-to-noise ratio s / n: 4~19, resolution: 511~992, peak intensity: 317-1726, peak area: 2853-35849.
[0022] The standard calibration solution described above contains characteristic protein of Escherichia coli and is used for molecular weight calibration of mass spectrometer.
[0023] The mass-to-charge ratios of the characteristic proteins of Escherichia coli are respectively: 2094, 2466, 3149, 4364, 5095, 5380, 6241, 6254, 6315, 6410, 6856, 7157, 7273, 7872, 8368, 9742, 10137, 10299, 12227. The preparation method of the characteristic proteins of Escherichia coli can be found in Chinese Patent ZL201510246677.8.
[0024] The bacterial protein extract described above includes 72%-75% ethanol, 65%-75% formic acid and acetonitrile.
[0025] In the above bacterial protein extract, 72%-75% ethanol, 65%-75% formic acid and acetonitrile are packaged separately.
[0026] The above-mentioned substrate saturated solution is a saturated solution of α-hydro-4-hydroxycinnamic acid using 48-52% acetonitrile and 2-3% trifluoroacetic acid as solvent.
[0027] In a fifth aspect, the present invention provides a method for detecting Escherichia coli for non-disease diagnosis purposes, the method comprising: extracting protein from the microorganism to be detected and performing MALDI-TOF MS detection; if the MS spectrum of the protein from the microorganism to be detected simultaneously has characteristic peaks of four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively, then the microorganism to be detected contains Escherichia coli; otherwise, the microorganism to be detected does not contain Escherichia coli.
[0028] In the above method, the protein of the microorganism to be detected is a small protein or polypeptide with a molecular weight of 2000-20000Da.
[0029] In the above method, the protein extraction of the microorganism to be tested includes the following steps: culturing the microorganism to be tested in solid or liquid form to the logarithmic growth phase, picking colonies or collecting bacterial precipitates by centrifugation, resuspending in 72%-75% ethanol, separating the precipitate, mixing the precipitate with 65%-75% formic acid, adding acetonitrile to mix, separating the supernatant, and obtaining the sample to be tested.
[0030] In the above protein extraction process, the volume ratio of 72%-75% ethanol, 65%-75% formic acid and acetonitrile is (1000-1400):(40-60):(40-60).
[0031] Preferably, the separation of the precipitate or supernatant may be carried out by centrifugation.
[0032] Preferably, the method for detecting Escherichia coli for non-disease diagnosis purposes comprises: mixing a bacterial protein extract with a positive standard to obtain a positive standard sample, spotting the sample to be tested on a mass spectrometer sample target, spotting a standard calibration solution and a positive standard sample at any point of the sample target, covering with a matrix saturated solution after drying, and performing MALDI-TOF MS detection after drying.
[0033] In the present invention, the microorganisms include one or more selected from bacteria, fungi, spirochetes, mycoplasmas and the like.
[0034] In a sixth aspect, the present invention provides a method for detecting Escherichia coli in marmots, which is the same as the above-mentioned method for detecting Escherichia coli in marmots for non-disease diagnosis purposes.
[0035] The beneficial effects of the present invention include at least: the present invention has screened and identified 4 characteristic peptides for specific screening of Escherichia coli in marmots, and developed a rapid detection kit based on the characteristic peptides. The kit was used to detect 258 strains of 60 genera and 193 species, including 5 strains of Escherichia coli in marmots and 253 strains of other genera and species. The results showed that all 5 strains of Escherichia coli in marmots were correctly identified with an accuracy of 100%; there were no misjudgments of the 253 strains of other genera and species, and the specificity of the kit was 100%. For simulated urine samples infected with Escherichia coli in marmots, the detection limit of the kit of the present invention was 10 4 CFU / mL (using Bruker's Microflex LRF model mass spectrometer). The detection kit of the present invention can complete the detection of 96 samples within 1 hour, with low cost, only 1-2 yuan per sample; the kit has high stability, can be stably used for 1 month at 4°C, and can be stably used for 1-2 years at ultra-low temperature; the kit is suitable for all currently commercialized MALDI-TOF mass spectrometers and has universal applicability. Therefore, the detection kit of the present invention has the characteristics of accuracy, specificity, high throughput, rapidity, ease of use, easy operation, and low cost. It can realize batch and rapid screening of Escherichia coli, and is suitable for clinical infection diagnosis, monitoring, epidemiological investigation, public health emergency response, etc. of Escherichia coli. It solves the bottleneck problem that the identification of Escherichia coli in the world currently relies only on whole genome sequencing and cannot be identified based on MALDI-TOF MS. It provides key technical support for the detection of Escherichia coli and the diagnosis of infection-related diseases and epidemic prevention and control. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0037] Figure 1 This is a spectrum of Escherichia coli detected by the kit of the present invention in Example 4 of the present invention; wherein A, B, C, D, and E are 5 strains of Escherichia coli.
[0038] Figure 2 This is the detection spectrum of Escherichia coli in simulated urine infected with marmots in Example 4 of the present invention; wherein, A: the bacterial concentration is 10 7 Sample spectrum of CFU / mL, B: bacterial concentration is 10 6 Sample spectrum of CFU / mL, C: bacterial concentration is 10 5 Sample spectrum of CFU / mL.
[0039] Figure 3 This is the detection spectrum of Escherichia coli in simulated urine infected with marmots in Example 4 of the present invention; wherein, A: the bacterial concentration is 10 4 Sample spectrum of CFU / mL, B: bacterial concentration is 10 3 Sample spectrum of CFU / mL, C: bacterial concentration is 10 2 Sample spectrum of CFU / mL. DETAILED DESCRIPTION
[0040] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the drawings of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0041] The five strains of Escherichia coli used in the following examples are Escherichia coli HT07316, HT080711, HT073105, HT080118 and HT073105, all of which are disclosed in the literature (Liu Sha. Nomenclature, characteristics, genome and virulence gene analysis of Escherichia coli [D]. Chinese Center for Disease Control and Prevention, 2015.).
[0042] The 258 strains used for accurate and specific identification in the following examples include the above-mentioned 5 strains of Escherichia coli and 253 strains of non-Escherichia coli, and the non-Escherichia coli covers 60 genera and 193 species, of which 60 genera include Escherichia coli ( Escherichia ) (Escherichia coli, Escherichia albertii, etc.), Shigella ( Shigella ) (Shigella flexneri, Shigella boydii, etc.), Acinetobacter spp. ( Acinetobacter ) (Acinetobacter baumannii, Acinetobacter haemolyticus, etc.), Aeromonas spp. ( Aeromonas ) (Aeromonas hydrophila, Aeromonas dakar), Alternaria spp. ( Alternaria Nees ) (Alternaria), Aspergillus ( Aspergillus ) (Aspergillus flavus, Aspergillus niger), Saccharomyces spp. ( Saccharomyces ) (Black yeast, Saccharomyces cerevisiae), Bacillus ( Bacillus ) (Bacillus anthracis, Bacillus cereus, etc.) 、 Bartonella spp. Bartonella ) (Bartonella bacilliformis, Bartonella krebsii), Bordetella spp. ( Bordetella ) (Bordetella bronchiseptica, Bordetella pertussis, etc.), Borrelia spp. ( Burgdorferi ) (Borrelia burgdorferi, etc.), Brucella spp. ( Brucella ) (Brucella abortus, Brucella canis, etc.), Pseudomonas spp. ( Pseudomonas ) (Pseudomonas sinusoids), Campylobacter spp. ( Campylobacter ) (Campylobacter jejuni, Campylobacter spp., etc.), Candida spp. ( Candida ) (Candida auris, Candida ximulon, etc.), Citrobacter spp. ( Citrobacter )(Citrobacter freundii), Clostridium spp.( Clostridium )(Clostridium difficile, Clostridium kluyveri), Corynebacterium spp. ( Corynebacterium )(Corynebacterium spp., Corynebacterium spp.), Cronobacter spp.( Cronobacter ) (Cronobacter dubliniensis, Cronobacter malonate, etc.), Enterobacter spp. ( Enterobacter ) (Enterobacter aerogenes, Enterobacter cloacae, etc.), Enterococcus spp. ( Enterococcus ) (Enterococcus faecium), Alcaligenes spp. ( Alcaligenes ) (Alcaligenes faecalis), Blastomyces spp. ( Blastochloris ) (Blastomyces dermatitidis), Fusarium spp. ( Fusarium ) (Fusarium solani), Ustilago ( Filobasidiella ) (Nail velvet black powder yeast), Geotrichum spp. ( Geotrichum ) (Candida species), Staphylococcus spp. ( Staphylococcus ) (Hemolytic Staphylococcus), Haemophilus ( Haemophilus) (Haemophilus influenzae, Haemophilus parainfluenzae), Vibrio spp. ( Vibrio ) (Vibrio parahaemolyticus, Vibrio alginolyticus), Hansenula sporangiophora ( Hanseniaspora ) (Hansenula sp.), Helicobacter spp. ( Helicobacter ) (Helicobacter pylori), Klebsiella spp. ( Klebsiella ) (Klebsiella pneumoniae), Kodacryocystis spp. ( Kodamaea ) (Omerkoda), Legionella spp. ( Legionella ) (Legionella Bozemanii, Legionella Dumovii), Desulfovibrio spp. ( Desulfovibrio ) (Desulfovibrio fairfieldii), Ralstonia spp. ( Lelliottia ) (Ralletella fluvii), Ubachia spp. ( Wolbachia ) (Wolbachia), Listeria spp. ( Listeria ) (Listeria monocytogenes), Lodelaborella spp. ( Lodderomyces ) (Lordeia longispora), Staphylococcus spp. ( Macrococcus ) (Giantococcus caseinolyticus, Staphylococcus aureus), Mycobacterium spp. ( Mycobacterium ) (Mycobacterium tuberculosis, Mycobacterium abscessus, etc.), Gluconobacter spp. ( Gluconobacter ) (Gluconobacter), Cytophaga ( Cellulophaga ) (Fermentative cellulophagus), Mycoplasma spp. ( Mycoplasma ) (Mycoplasma genitalium, Mycoplasma hominis), Neisseria spp. ( Neisseria ) (Neisseria meningitidis, Neisseria meningitidis), Nocardia spp. ( Nocardia ) (Brazilian Nocardia, Menocardia, etc.), Photobacterium spp. ( Photob ) (Photobacterium mermanii), Plesiomonas spp. ( Plesiomonas ) (Pleistomonas shigellae), Proteus spp. ( Proteus ) (Proteus mirabilis), Ustilago farfara ( Moesziomyces ) (Ustilago officinalis), Rhodotorula spp. ( Rhodotorula) (Rhodotorula), Salmonella spp. ( Salmonella ) (Salmonella choleraesuis, Salmonella paratyphi, etc.), Schizophyllum spp. ( Schizophyllum ) (Schizophyllum), Serratia spp. ( serratia ) (Serratia marcescens), Rhodobacterium salinarum ( Natronorubrum ) (Bangor Lake Halobacterium), Trichosporon spp. ( Trichosporon ) (Trichosporon asahii), Sphingomonas spp. ( Sphingomonas ) (Sphingomonas paucimobilis), Trichosporon spp. ( Trichosporon ) (Trichosporon monteriodactylum), Wickham's yeast ( Wickerhamomyces ) (Wickham's yeast), Yersinia spp. ( Yersinia) (Yersinia pestis, Yersinia pseudotuberculosis).
[0043] Example 1 Screening and determination of characteristic peptides of Escherichia coli
[0044] First, the peak statistics calculation function of Bruker's ClinProTools software was used to find statistically significant (p<0.05) differential peaks (peptides) in the range of 2000-20000Da between Escherichia coli and non-Escherichia coli pathogens. Bruker's FlexAnalysis software was used to compare and analyze a total of 272 peptide mass fingerprints of Escherichia coli and all serotypes of Escherichia coli, Shigella and other Gram-negative and Gram-positive bacteria. Combining the comparison analysis results of the two software and two methods, four characteristic peptides of Escherichia coli were determined, and the mass spectrum information of the characteristic peptides is shown in Table 1. The accuracy and specificity of the above four characteristic peptides were verified using 258 strains of bacteria including 60 genera and 193 species. The verification results showed that the accuracy and specificity of the combination of four characteristic peptides for the identification of Escherichia coli in marmots were both 100%. Therefore, the present invention subsequently used these four characteristic peptides as species-specific peptides of Escherichia coli in marmots, and developed subsequent detection kits based on these four characteristic peptides.
[0045] Table 1 Information on characteristic peptides (specific peaks) of Escherichia coli MALDI-TOF MS
[0046]
[0047] Example 2 Preparation of positive standard
[0048] The ethanol / formic acid extraction method was used to extract bacterial proteins from 5 strains of Escherichia coli isolated from Himalayan marmots in Qinghai Province. The specific steps are as follows.
[0049] (1) Take an appropriate amount of bacterial colonies and add them to an EP tube containing 300 µL ddH2O to fully dissolve the bacteria.
[0050] (2) Add 900 µL of anhydrous ethanol and mix well.
[0051] (3) Centrifuge at 12,000 rpm for 1 min and discard the supernatant.
[0052] (4) Add 50 µL 70% formic acid and mix well.
[0053] (5) Add 50 µL of acetonitrile and vortex to mix.
[0054] (6) Centrifuge at 12,000 rpm for 2 min and collect the supernatant, which is the extracted bacterial protein.
[0055] The supernatant in step (6) was used to spot the target, covered with a matrix and dried, and then data was collected using MALDI-TOF MS.
[0056] Analyze the peak of each strain, and adjust the concentration of protein samples to make the peak of each sample consistent when the laser intensity is fixed. Mix 5 samples in equal proportions according to volume ratio, and dilute the samples by 10, 20, 50, 100, and 200 times. Use two MALDI-TOF MS mass spectrometers (CP-Light 1000 of Xiamen Jinnuohua Technology Co., Ltd. and Microflex LRF of Bruker, Germany) for data acquisition. The protein sample with a concentration higher than the sample concentration that can stably collect signals is used as the positive standard mother solution, spin-dried and frozen at -80℃, and diluted to the optimal concentration as required when used.
[0057] Example 3 Rapid Identification Kit for Escherichia coli Based on MALDI-TOF MS
[0058] This embodiment provides a rapid identification kit for Escherichia coli based on MALDI-TOF MS, which includes a positive standard, a standard calibration solution, a bacterial protein extract and a matrix saturation solution. Wherein, the preparation method of the positive standard is as described in Example 2; the standard calibration solution includes Escherichia coli characteristic protein (the mass-to-charge ratios of the Escherichia coli characteristic protein are: 2094, 2466, 3149, 4364, 5095, 5380, 6241, 6254, 6315, 6410, 6856, 7157, 7273, 7872, 8368, 9742, 10137, 10299, 12227; the preparation method of Escherichia coli characteristic protein refers to Chinese patent ZL201510246677.8); the bacterial protein extract includes: 75% chromatographic grade ethanol, 70% chromatographic grade formic acid, and chromatographic grade acetonitrile; the matrix saturated solution is a saturated solution of α-hydrogen-4-hydroxycinnamic acid (CHCA) in 50% acetonitrile and 2.5% trifluoroacetic acid, and CHCA is a commercially available product (Sigma).
[0059] The kit determines whether an unknown bacterial sample or a pathogen in the sample is Escherichia coli based on whether the MS spectrum detected by MALDI-TOF MS has characteristic peptide mass-to-charge ratios of m / z2882.70±1.06, m / z 4853.93±2.22, m / z 5764.78±2.31 and m / z 10516.16±4.23.
[0060] The steps for using the above kit are as follows.
[0061] Collect the test bacteria that have been cultured to the logarithmic growth phase, and use bacterial protein extraction solution to extract protein (resuspend the bacterial precipitate in 1.2mL 75% ethanol and mix well, centrifuge at 12,000rpm for 1min, separate the precipitate, add 50µL 70% formic acid to the precipitate and mix well, then add 50µL acetonitrile and mix well, centrifuge at 12,000rpm for 2min, and separate the supernatant). Take 1µL of supernatant and apply it to the sample target. After natural drying, cover it with 1µL matrix saturated solution; at the same time, apply at least one positive standard sample point and standard calibration solution point at any position of the sample target, and cover it with matrix saturated solution. After the sample is dried naturally at room temperature on the target, MALDI-TOFMS is used to collect data. Before collecting sample data, the mass axis of the mass spectrometer is calibrated with standard calibration solution, and the calibrated mass range is m / z 2000-20000. Check the peptide mass fingerprint of the positive standard and determine the peaks of the characteristic peptides m / z 2882.70±1.06, m / z 4853.93±2.22, m / z 5764.78±2.31 and m / z 10516.16±4.23; after confirming that the above four characteristic peaks appear, perform subsequent analysis on the sample to be tested and give the test results: if the four characteristic peptide peaks are detected at the same time, it is determined that the sample to be tested contains Escherichia coli.
[0062] Example 4 Evaluation of the actual detection effect of the kit
[0063] The detection effect of the rapid identification kit for Escherichia coli based on MALDI-TOF MS of Example 3 was evaluated as follows.
[0064] 1. Colony sample detection
[0065] The kit developed by the present invention was used to detect 258 strains of 60 genera and 193 species, including 5 strains of Escherichia coli and 253 strains of other genera and species; among them, Escherichia coli and Shigella closely related to Escherichia coli included all serotypes (enterohemorrhagic Escherichia coli, pathogenic Escherichia coli, enterotoxigenic Escherichia coli, enteroinvasive Escherichia coli and coagulative Escherichia coli; Shigella dysenteriae, Shigella flexneri, Shigella boydii, Shigella sonnei).
[0066] The bacteria to be tested were cultured to the logarithmic growth phase, and the bacterial protein sample was extracted using the bacterial protein extract in the kit. An appropriate amount of the extract was added to the positive standard tube, and 1 µL of the sample was spotted on the sample target. At the same time, two standard calibration solution spots and positive standard spots were spotted at any point. After drying, 1 µL of matrix saturated solution was covered on each sample point. After drying at room temperature, the sample points were subjected to MALDI-TOF MS detection.
[0067] MALDI-TOF MS detection uses Bruker's Micrflex LRF mass spectrometer, and the data acquisition mode is reflection mode for equipment mass axis calibration and data acquisition. After the data acquisition is completed, the FlexAnalysis software that comes with the equipment is first used to view the peak value of the positive standard to determine that the four characteristic peaks (m / z 2882.70±1.06, m / z 4853.93±2.22, m / z5764.78±2.31 and m / z 10516.16±4.23) are all present and meet the various index conditions shown in Table 1. The sample to be tested can be judged: If the above four characteristic peaks appear at the same time, the sample is Escherichia coli, otherwise it is not Escherichia coli. The results showed that using the kit of the present invention, 5 strains of Escherichia coli were accurately identified ( Figure 1 ), there was no misjudgment of other non-marmot Escherichia coli, indicating that the accuracy and specificity of the detection kit were both 100%.
[0068] 2. Simulated urine infection sample detection
[0069] (1) Methods
[0070] Two strains of Escherichia coli were cultured in LB agar solid medium at 37°C overnight until the logarithmic growth phase. An appropriate amount of bacteria was scraped and suspended in PBS buffer to prepare a McFarland turbidity of 1 (3.0×10 8 CFU / ml). The diluent was used as the mother solution and gradient dilution was prepared to 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 CFU / mL 1mL dilution, centrifuge at 13000rpm for 5min, and discard the supernatant. Add 1mL of freshly collected midstream urine to each concentration tube, mix well by blowing, and prepare 1mL of urine containing each concentration of bacteria to simulate infection samples, centrifuge at 13000rpm for 5min and discard the supernatant; add 1mL of PBS buffer to the precipitate for suspension and washing, centrifuge at 13000rpm for 3min and discard the supernatant. Add 1mL of 75% alcohol to each tube to inactivate the bacteria, centrifuge at 13000rpm for 3min, and discard the supernatant. Add 10µL of 70% formic acid, mix well by blowing, add 10µL of acetonitrile, mix thoroughly, and centrifuge at 13000rpm for 3min. Take the supernatant spot target, cover the matrix and dry it, and then put it on the machine for data acquisition and data analysis. The MALDI-TOF mass spectrometer model is: Microflex LRF of Bruker, data acquisition adopts linear mode, and the data acquisition range is 2000-20000Da.
[0071] (2) Results
[0072] The results showed that as the amount of bacteria in urine increased, the quality of the spectrum gradually improved. 2 CFU / ml, only one target peak appears, and the bacterial concentration reaches 10 4 CFU / ml, all four target peaks (m / z 2882.70, 4853.93, 5764.78, 10516.16) were detectable, so this concentration was the minimum detection limit for the detection of Escherichia coli infection in urine of woodchucks using the Microflex LRF mass spectrometer ( Figure 2 and Figure 3 ).
[0073] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. The use of a characteristic peptide combination as a marker for detecting Escherichia coli in marmots or in detecting Escherichia coli in marmots, characterized in that: The characteristic peptide segment combination includes four characteristic peptide segments with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23 respectively; The application comprises: performing MALDI-TOF MS detection on the protein of the microorganism to be detected; if the MS spectrum of the protein of the microorganism to be detected simultaneously has characteristic peaks of four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively, the microorganism to be detected contains Escherichia coli; otherwise, the microorganism to be detected does not contain Escherichia coli; The protein of the microorganism to be detected is a small protein or polypeptide with a molecular weight of 2000-20000 Da.
2. Use of a reagent for detecting a characteristic peptide combination in the preparation of a kit for detecting Escherichia coli or screening for Escherichia coli infection in marmots, wherein the characteristic peptide combination includes four characteristic peptides with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively.
3. A method for detecting Escherichia coli in marmots for non-disease diagnosis purposes, characterized in that: The method comprises: extracting proteins of the microorganism to be detected and performing MALDI-TOF MS detection; if the MS spectrum of the protein of the microorganism to be detected simultaneously has characteristic peaks of four characteristic peptide segments with mass-to-charge ratios m / z of 2882.70±1.06, 4853.93±2.22, 5764.78±2.31 and 10516.16±4.23, respectively, the microorganism to be detected contains Escherichia coli; otherwise, the microorganism to be detected does not contain Escherichia coli.
4. The method according to claim 3, characterized in that The protein of the microorganism to be tested is a small protein or polypeptide with a molecular weight of 2000-20000 Da; And / or, the extracting of protein from the microorganism to be detected comprises the following steps: The microorganism to be tested is cultured in solid or liquid form to the logarithmic growth phase, colonies are picked or bacterial precipitates are collected by centrifugation, resuspended in 72%-75% ethanol, the precipitate is separated, the precipitate is mixed with 65%-75% formic acid, acetonitrile is added and mixed, the supernatant is separated, and the sample to be tested is obtained.
5. The method according to claim 3 or 4, characterized in that: The method for detecting Escherichia coli for non-disease diagnosis purposes comprises: mixing a bacterial protein extract with a positive standard to obtain a positive standard sample, spotting the sample to be tested on a mass spectrometer sample target, spotting a standard calibration solution and a positive standard sample at any point of the sample target, covering with a matrix saturated solution after drying, and performing MALDI-TOF MS detection after drying.
